Avivagen Inc. reported earnings results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported sales was CAD 0.077683 million compared to CAD 0.088438 million a year ago. Net loss was CAD 1.24 million compared to CAD 1.3 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.
For the six months, sales was CAD 0.143722 million compared to CAD 0.359595 million a year ago. Net loss was CAD 2.4 million compared to CAD 2.86 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.05 a year ago.